Cadence Pharmaceuticals (CADX)

Add to Watchlists
Create an Alert
13.98 +0.00  +0.00% NASDAQ Mar 19, 8:00PM BATS Real time Currency in USD
View Full Chart
CADX Price Chart
View All Events

CADX Events

Date Type Description
Feb 28 Earnings Q4 2013 Cadence Pharmaceuticals Inc. Earnings Results. Estimate: -0.03.
Feb 28 Misc Q4 2013 Cadence Pharmaceuticals Inc. Earnings Conference Call
Feb 11 Misc Mallinckrodt Plc to Acquire Cadence Pharmaceuticals, Inc. For $14.00 Per Share, in Cash
Nov 05 Misc Cadence Pharmaceuticals 3rd Quarter 2013 Earnings Call
Nov 05 Earnings Cadence Pharmaceuticals 3rd Quarter 2013 Earnings Release. Estimate: -0.08.
Jul 31 Misc Cadence Pharmaceuticals 2nd Quarter 2013 Earnings Release
Jul 31 Earnings Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2013 Financial Results on July 31, 2013. Estimate: -0.11.
Jun 12 Misc AGM Event for Cadence Pharmaceuticals, Inc
May 02 Misc Q1 2013 Earnings Conference Call
May 02 Earnings Q1 2013 Earnings Release. Estimate: -0.15.
View All Performance Charts

CADX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Cadence Pharmaceuticals is up 169.9% over the last year vs S&P 500 Total Return up 23.54%, Jazz Pharmaceuticals up 148.9%, and Mallinckrodt up N/A.

Get Quote for

PDF Report for CADX

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download CADX Pro Report PDF

Portfolio Strategies Featuring CADX

Did Cadence Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

CADX Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: December 31, 2013
  • Last Fiscal Year End: December 31, 2013

Cadence Pharmaceuticals, Inc. develops drugs for use in hospitals. It's product Ofirmev is used for pain management.

Recent Quotes

Symbol Price Chg Chg % Market Cap
CADX 13.98 +0.00 +0.00% 1.247B
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.